Long-term use of meloxicam tablets for rheumatoid arthritis is associated with greater impairment of renal and hepatic function. Meloxicam tablets have an inhibitory effect on the synthesis of renal prostaglandins, which play a supportive role in the maintenance of renal perfusion, and the use of this product may lead to significant renal compensatory disorders. There is also the possibility of elevated serum transaminases or other parameters of liver function. Meloxicam belongs to the group of non-steroidal anti-inflammatory drugs, which can be anti-inflammatory and analgesic, treating rheumatoid arthritis and so on. Adverse reactions such as dyspepsia, nausea, vomiting, rash, anemia, and rarely edema, hypertension, palpitations (rapid heartbeat, often accompanied by panic) and other cardiovascular adverse reactions may occur. It is contraindicated in people who are allergic to the active ingredients of the product, or have severe liver or kidney function impairment. Also based on the fact that it has serious adverse reactions is not recommended for long-term use. The above drugs should be used under the supervision of a doctor. Patients with rheumatoid arthritis are advised to consult the rheumatology and immunology department in a timely manner, under the guidance of a doctor for standardized treatment and regular follow-up.